Minimizing treatment without compromising cure with primary surveillance for clinical stage I embryonal predominant nonseminomatous testicular cancer: A population based analysis from British Columbia

Journal of Urology

Volumn 174, Issue 6, 2005, Pages 2209-2213

  Al Tourah, Abdulwahab J ^a   Murray, Nevin ^a   Coppin, Chris ^a   Kollmannsberger, Christian ^a   Man, Ada ^a   Chi, Kim N ^a  

^a BRITISH COLUMBIA CANCER AGENCY   (Canada)

Author keywords

Carcinoma, embryonal; Testicular neoplasms, epidemiology, lymph node excision

Indexed keywords

CISPLATIN; ETOPOSIDE;

ADOLESCENT; ARTICLE; CANADA; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER RELAPSE; CANCER SURGERY; CANCER SURVIVAL; EMBRYONAL CARCINOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MALE; NON SEMINOMATOUS GERMINOMA; ORCHIECTOMY; POPULATION RESEARCH; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TESTIS CANCER;

EID: 27744588847     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ju.0000181810.22617.f8     Document Type: Article

References (17)

1. Einhorn, L. H.: Testicular cancer as a model for a curable neoplasm: The Richard and Hinda Rosenthal Foundation Award Lecture. Cancer Res, 41: 3275, 1981
2. Read, G., Stenning, S. P., Cullen, M. H., Parkinson, M. C., Horwich, A., Kaye, S. B. et al: Medical Research Council prospective study of surveillance for stage I testicular teratoma. Medical Research Council Testicular Tumors Working Party. J Clin Oncol, 10: 1762, 1992
3. Sogani, P. C., Perrotti, M., Herr, H. W., Fair, W. R., Thaler, H. T. and Bosl, G.: Clinical stage I testis cancer: long-term outcome of patients on surveillance. J Urol, 159: 855, 1998
4. Colls, B. M., Harvey, V. J., Skelton, L., Frampton, C. M., Thompson, P. L, Bennett, M. et al: Late results of clinical stage I nonseminomatous germ cell testicular tumours: 17 years' experience in a national study in New Zealand. BJU Int, 83: 76, 1999
5. Spermon, J. R., Roeleveld, T. A., van der Poel, H. G., Hulsbergenvan de Kaa, C. A., Ten Bokkel Huinink, W. W., van de Vijver, M. et al: Comparison of surveillance and retroperitoneal lymph node dissection in stage I nonseminomatous germ cell tumors. Urology, 59: 923, 2002
6. Gels, M. E., Hoekstra, H. J., Sleijfer, D. T., Marrink, J., de Bruijn, H. W., Molenaar, W. M. et al: Detection of recurrence in patients with clinical stage I nonseminomatous testicular germ cell tumors and consequences for further follow-up: a single-center 10-year experience. J Clin Oncol, 13: 1188, 1995
7. Freedman, L. S., Parkinson, M. C., Jones, W. G., Oliver, R. T., Peckham, M. J., Read, G. et al: Histopathology in the prediction of relapse of patients with stage I testicular teratoma by orchiectomy alone. Lancet, 2: 294, 1987
8. Albers, P., Siener, R., Kliesch, S., Weissbach, L., Krege, S., Sparwasser, C. et al: Risk factors for relapse in clincal stage I nonseminomatous testicular germ cell tumors: results of the German Testicular Cancer Study Group Trial. J Clin Oncol, 21: 1505, 2003
9. Vergouwe, Y., Steyerberg, E. W., Eijkemans, M. J., Albers, P. and Habbema, J.: Predictors of occult metastasis in clincal stage I nonseminoma: a systematic review. J Clin Oncol, 21: 4092, 2003
10. Sweeney, C. J., Hermans, B. P., Heilman, D. K., Foster, R. S., Donohue, J. P. and Einhorn, L. H.: Results and outcome of retroperitoneal lymph node dissection for clinical stage I embryonal carcinoma-predominant testis cancer. J Clin Oncol, 18: 358, 2000
11. Pont, J., Albrecht, W., Postner, G., Seilner, F., Angel, K. and Holtl, W.: Adjuvant chemotherapy for high-risk clinical stage I nonseminomatous testicular germ cell cancer: long-term results of a prospective trial. J Clin Oncol, 14: 441, 1996
12. Band, P. R., Gaudette, L. A., Hill, G. B., Holowaty, E. J., Huchcroft, S. A., Johnston, G. M. et al: The Making of the Canadian Cancer Registry. Cancer Incidence in Canada and Its Regions, 1969 to 1988. Ottawa: Ministry of Supply and Services Canada, 1993
13. Kaplan, E. L. and Meier, P.: Nonparametric estimation from incomplete observations. J Amer Stat Assoc, 53: 457, 1958
14. BC Cancer Agency Cancer Management Guidelines website: http://www.bccancer.bc.ca/HPI/CancerManagementGuidelines/Genitourinary/Testis/ Management/Followup.htm. Accessed December 2004
15. Cullen, M. H., Stenning, S. P., Parkinson, M. C., Fossa, S. D., Kaye, S. B., Horwich, A. H. et al: Short-course adjuvant chemotherapy in high-risk stage I nonseminomatous germ cell tumors of the testis: a Medical Research Council report. J Clin Oncol, 14: 1106, 1996
16. International Germ Cell Consensus Classification: a prognostic factor-based staging system for metastatic germ cell cancers. International Germ Cell Cancer Collaborative Group. J Clin Oncol, 15: 594, 1997
17. Hao, D., Seidel, J., Brant, R., Alexander, F., Ernst, D. S., Summers, N. et al: Compliance of clinical stage I nonseminomatous germ cell tumor patients with surveillance. J Urol, 160: 768, 1998